Isofol Medical AB (ISOFOL) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.089x

Based on the latest financial reports, Isofol Medical AB (ISOFOL) has a cash flow conversion efficiency ratio of -0.089x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-10.78 Million ≈ $-1.16 Million USD) by net assets (Skr120.62 Million ≈ $12.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Isofol Medical AB for the company's overall valuation and market capitalisation.

Isofol Medical AB - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Isofol Medical AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Isofol Medical AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Isofol Medical AB ranked by their cash flow conversion efficiency. See Isofol Medical AB (ISOFOL) cash flow to debt to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Xbrane Biopharma AB ST:XBRANE	-0.009x
DAP Corporation KQ:066900	-0.045x
Studio Mir Co. Ltd. KQ:408900	-0.036x
Caldwell Partners International Inc TO:CWL	-0.159x
HG Capital Trust PLC LSE:HGT	-0.016x
Ratio Energies LP TA:RATI-L	0.145x
Investors House HE:INVEST	-0.089x
Alpcot Holding AB Series B ST:ALPCOT-B	-0.159x

Annual Cash Flow Conversion Efficiency for Isofol Medical AB (2015–2025)

The table below shows the annual cash flow conversion efficiency of Isofol Medical AB from 2015 to 2025. View ISOFOL live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr107.87 Million ≈ $11.61 Million	Skr-51.94 Million ≈ $-5.59 Million	-0.481x	+10.62%
2024-12-31	Skr77.94 Million ≈ $8.39 Million	Skr-41.99 Million ≈ $-4.52 Million	-0.539x	-24.51%
2023-12-31	Skr121.43 Million ≈ $13.07 Million	Skr-52.54 Million ≈ $-5.65 Million	-0.433x	+64.10%
2022-12-31	Skr158.48 Million ≈ $17.05 Million	Skr-190.97 Million ≈ $-20.55 Million	-1.205x	-103.52%
2021-12-31	Skr318.23 Million ≈ $34.25 Million	Skr-188.43 Million ≈ $-20.28 Million	-0.592x	+75.41%
2020-12-31	Skr66.57 Million ≈ $7.16 Million	Skr-160.27 Million ≈ $-17.25 Million	-2.408x	-71.58%
2019-12-31	Skr104.91 Million ≈ $11.29 Million	Skr-147.21 Million ≈ $-15.84 Million	-1.403x	-302.20%
2018-12-31	Skr265.01 Million ≈ $28.52 Million	Skr-92.46 Million ≈ $-9.95 Million	-0.349x	-93.21%
2017-12-31	Skr343.03 Million ≈ $36.92 Million	Skr-61.94 Million ≈ $-6.67 Million	-0.181x	+98.06%
2016-12-31	Skr6.10 Million ≈ $656.35K	Skr-56.90 Million ≈ $-6.12 Million	-9.330x	+66.45%
2015-12-31	Skr1.32 Million ≈ $142.27K	Skr-36.77 Million ≈ $-3.96 Million	-27.812x	--

About Isofol Medical AB

ST:ISOFOL Sweden Biotechnology

Market Cap

$22.39 Million

Skr208.02 Million SEK

Market Cap Rank

#24847 Global

#487 in Sweden

Share Price

Skr0.74

Change (1 day)

+1.37%

52-Week Range

Skr0.58 - Skr0.89

All Time High

Skr33.00